Mark G Edwards insider trades: Acelrx Pharmaceuticals (ACRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
13 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 12, 2019 | ACRX | ↑ Buy | 25,000 | $1.78 | $45K | Direct | Nov 12, 2019 (0d) |
| Aug 26, 2019 | ACRX | ↑ Buy | 15,000 | $2.19 | $33K | Direct | Aug 26, 2019 (0d) |
| Mar 12, 2019 | ACRX | ↑ Buy | 19,000 | $2.99 | $57K | Direct | Mar 12, 2019 (0d) |
| Nov 15, 2018 | ACRX | ↑ Buy | 20,700 | $2.82 | $58K | Direct | Nov 15, 2018 (0d) |
| Aug 7, 2018 | ACRX | ↑ Buy | 5,300 | $2.84 | $15K | Direct | Aug 8, 2018 (1d) |
| Jun 5, 2018 | ACRX | ↑ Buy | 5,000 | $3.35 | $17K | Direct | Jun 5, 2018 (0d) |
| Nov 14, 2017 | ACRX | ↑ Buy | 30,000 | $1.90 | $57K | Direct | Nov 15, 2017 (1d) |
| Aug 24, 2017 | ACRX | ↑ Buy | 5,000 | $3.02 | $15K | Direct | Aug 24, 2017 (0d) |
| May 12, 2016 | ACRX | ↑ Buy | 15,000 | $3.15 | $47K | Direct | May 12, 2016 (0d) |
| May 7, 2015 | ACRX | ↑ Buy | 40,000 | $3.13 | $125K | Direct | May 7, 2015 (0d) |
| Jun 6, 2013 | ACRX | ↑ Buy | 10,000 | $8.10 | $81K | Direct | Jun 10, 2013 (4d) |
| Dec 1, 2011 | ACRX | ↑ Buy | 10,000 | $2.79 | $28K | Direct | Dec 2, 2011 (1d) |
| Nov 14, 2011 | ACRX | ↑ Buy | 40,000 | $2.90 | $116K | Direct | Nov 16, 2011 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark G Edwards's insider trades
Mark G Edwards is a director at Acelrx Pharmaceuticals (ACRX). Since Nov 14, 2011, Mark has reported 13 open-market purchases worth $694K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (14 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.